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T
he transfer of a donor’s healthy mitochondria
into a woman’s egg or early embryo aims to
prevent a child from inheriting mitochondrial
disease from its mother. In February 2015 the
United Kingdom became the ﬁrst country to
allow the technique, and last month the US Institute of Medi-
cine also determined that mitochondrial donation is accept-
able in some circumstances.  
Current laws and regulations in Australia are unlikely to
allow this treatment to be used clinically so that children can
be born with donor mitochondria. However, in all states and
territories (except Western Australia), undertaking embryo
research into at least some methods of mitochondrial dona-
tion may be possible under an appropriate licence. 
So far, no such licences have been granted. There are also
no plans to review these laws, with the most recent review in
2011 rejecting any change to allow mitochondrial donation.
Should Australia now follow these overseas developments? 
Mitochondrial Disease
Mitochondria are organelles within our cells that are respon-
sible for energy generation. It’s thought that they originated
in bacteria but now exist in our cells in a symbiotic relation-
ship. 
Mitochondrial disease occurs when these mitochondria
don’t work properly. These diseases take many forms but often
they affect energy-intensive body parts such as the brain, liver
or heart. Mitochondrial disease is debilitating, is often fatal, and
at present there’s no cure.
Many mitochondrial diseases are caused by problems in the
DNA of the mitochondria themselves, which is separate from
the DNA found in a cell’s nucleus. Mitochondria are only
passed on via the mother; a pattern known as matrilineal inher-
itance. This means that a man with mitochondrial disease will
not pass it to his children. Whether a woman passes it to her
children depends on the balance of healthy and mutated mito-
chondria in her egg cells. 
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Is there any ethical reason why legislation should prevent the use of donor mitochondria in
cases where children are likely to inherit mitochondrial disease from their mothers?
Should Australia Allow
Mitochondrial Donation?
no
b
ea
st
so
fie
rc
e
Mitochondrial DNA is also prone to developing new muta-
tions. This makes it hard to predict reliably whether and how
someone will be affected by mitochondrial disease. 
Mitochondrial replacement is proposed as a way of preventing
disease from being passed from mother to child. One tech-
nique, maternal spindle transfer, removes the chromosomes
from an egg cell with damaged mitochondria and inserts them
into a donated egg that has healthy mitochondria. This egg is
then fertilised and implanted in much the same way as stan-
dard in vitro fertilisation. 
Another technique, pronuclear transfer, transplants the
nuclei of a sperm and egg (together termed the “pronuclei”)
from an embryo created by the parents to an early embryo
created using the father’s sperm and a donated egg that has had
its own pronuclei removed. 
Both techniques will result in an embryo that has nuclear
DNA from the mother and father, and mitochondria from a
donor. Any child created would be genetically linked, through
mitochondrial DNA, to an egg donor as well as to his or her main
genetic parents – hence the expression “three-parent IVF”.
“Three-Parent” IVF?
Should it matter that a child has three biological parents? The
ﬁrst thing to think about here is whether mitochondrial donors
are really a “parent”. While the children created will be genet-
ically linked to the donors, it’s far from clear that this link is suﬃ-
cient to make them parents.
Only around 0.1% of our genes are contained in mitochon-
dria (the other 99.9% is in the cell’s nuclei), so the donor only
provides a tiny fraction of the child’s genetic material. That said,
this DNA is important: it determines the difference between
health and illness. It’s also present in thousands of copies per cell,
while there are only two copies of each gene in the nucleus. 
We can also ask whether there’s really anything bad about
children having a biological link with three people. There are
already lots of families that only exist because of the biological
input of a third person, such as children created using tradi-
tional egg donation or through surrogacy. In the case of egg
donation, for example, the child’s “social mother” becomes
pregnant and gives birth to her child but she is not genetically
related to her baby because the egg came from a donor. 
Thus it’s not clear that “three parent IVF” (if that’s what
mitochondrial donation is) would be all that different from
practices that we already accept.
Genetic Modification
Another concern is that mitochondrial donation is a kind of
genetic modiﬁcation that will affect future generations. This
has ethical relevance as it could permanently change the gene
pool. Some people are concerned that this sort of genetic modi-
ﬁcation is too dangerous due to the unknown nature of its
effects (e.g. the US Institute of Medicine recommends that
this technique be used only to implant male embryos to avoid
passing on donor mitochondria). Others object to it because
they think it is wrong to “interfere” with human nature to
this extent.
But against this, it could also be argued that mitochondrial
replacement isn’t really modiﬁcation. Donated mitochondria
are naturally occurring (in the donor’s egg) and not engineered
or manufactured. 
There is also no change at the level of DNA; rather, it involves
the substitution of one set of mitochondria for another. This
means that we’re using genetic material that already occurs in
nature, not adding anything new or artiﬁcial. According to this
view, mitochondrial replacement is more like an organ trans-
plant than like genetic engineering.
Furthermore, many different policy decisions have major
effects on those yet to be born, such as decisions about the
environment and climate change, or whether to go to war.
Mitochondrial replacement is not unique in affecting the
future and, given the small numbers involved – around one
in 5000 people will develop serious mitochondrial disease – its
effects may be quite limited compared with other things that
we do.
The Ethics of Safety and Risk
In the UK, a high-level scientiﬁc review committee deemed
mitochondrial donation safe enough to proceed to clinical
use. However, this doesn’t guarantee that this treatment will
be risk-free. Debates are ongoing in the scientiﬁc literature
about what effects might occur as a result of mitochondrial
transfer. Some worry that data from experiments in species
such as mice and fruit ﬂies, in which swapping mitochondria
had untoward effects, have been overlooked. Others argue
that these data are not transferable to humans or are being
over-interpreted.
From an ethical perspective, the key issue is how we should
decide on the acceptable level of risk for mitochondrial dona-
tion. Sometimes a precautionary approach can be taken, in
which the use of a new technology is limited until serious risks
are known to be minimised. However, this can lead to long
delays. It is also important to keep in mind that the main alter-
native for these families – having a child affected by mito-
chondrial disease – is so bad that a certain level of risk is justiﬁed
in order to prevent this suffering.
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“... the main alternative for these
families – having a child affected by
mitochondrial disease – is so bad that a
certain level of risk is justified”
Is Mitochondrial Replacement Unnecessary?
Some have also argued that we shouldn’t allow mitochondrial
replacement because it’s not needed. The argument here is that
affected parents already have other options so there’s no need
to develop mitochondrial replacement. For example, Cana-
dian bioethicist Françoise Baylis argues that:
women at risk of having children with mitochondrial disease can have
their own children using much less risky alternatives. For example, they
can make a baby the old fashioned way, have prenatal diagnosis and,
if the fetus is affected, they can choose to have a termination of
pregnancy. Alternatively, they can make an embryo using IVF and have
preimplantation genetic diagnosis... They can have IVF and egg
donation or embryo donation. They can choose to adopt a child. Using
one or other of these options, women can become mothers without
putting their future children in harm’s way with the use of
mitochondrial replacement technology.
While these are all potential options, prenatal diagnosis or
preimplantation genetic diagnosis are not possible for many
couples who are at risk of passing on mitochondrial disease. If a
woman's eggs have mainly or only mutated mitochondria, then
any child born from one of those eggs will have the same high
level of mutation. No amount of selecting is going to change that.
And ﬁnding a suitable egg donor or adoptive child isn’t easy.
In 2013, only 406 babies were born from egg donation in Australia
– a fraction of the 300,000 or so children born that year. Australian
couples seeking egg donation also often travel overseas to ﬁnd a
donor, prompting the Australian Health Ethics Committee to
propose legalising payment for egg donors here. Additionally, the
most recent adoption statistics for Australia show that there were
only 317 adoptions in 2013–14. Of these, only 12% of adoptions
involved children under 12 months of age. 
It is also apparent that – in common with many other fami-
lies – couples at risk of passing on a mitochondrial condition
attach value to the genetic link between parent and child and
would very much like to have children who are both genetically
“theirs” and free from mitochondrial disease.
A Right to Know?
Australian guidelines state that “persons conceived using ART
procedures are entitled to know their genetic parents”. This raises
the question of whether mitochondrial egg donors should be
considered as “genetic parents” for these purposes. It also raises the
question of whether children created as a result of mitochondrial
donation should have a right to know who the egg donor was. 
However, it might also be argued that mitochondrial donors
aren’t biological parents because their genetic contribution is so
limited and that – unlike “regular” egg and sperm donors – chil-
dren created via mitochondrial donation won’t inherit their
donors’ most important personal characteristics, which pass via
cell nuclei. 
If donor information can be stored without imposing huge
costs on clinics and without putting off too many donors, a case
can be made for storing information about mitochondrial donors
with a view to releasing this when the children created reach matu-
rity. Those who don’t want to access this information needn’t do
so, but some may have a strong desire to know more about their
origins and may be frustrated or distressed if information is with-
held. 
Thus it may be best to err on the side of caution and to retain
donor information for those who want it. 
Moving Forward, Cautiously
It’s too early to say whether mitochondrial replacement tech-
niques can be developed that are suﬃciently safe and effective for
widespread clinical use . As with any new medical treatment, thor-
ough evaluation and research is needed. There is, however, no
conclusive ethical argument against proceeding with this research.
In addition, given the importance to many people of having a
child who is both genetically “theirs” and free from mitochon-
drial disease, there’s a strong case for allowing it to proceed,
provided that there’s rigorous regulation and monitoring.
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